Shylet Chengedza, Ph.D.
Affiliations: | 2009 | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Biochemistry, Oncology, Cell BiologyGoogle:
"Shylet Chengedza"Parents
Sign in to add mentorDoris M. Benbrook | grad student | 2009 | University of Oklahoma Health Sciences Center | |
(Molecular mechanism of apoptosis induction by SHetA2 in ovarian cancer cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chengedza S, Benbrook DM. (2010) NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis. Anti-Cancer Drugs. 21: 297-305 |
Moxley KM, Chengedza S, Benbrook DM. (2010) Erratum to “Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents” [Gynecol. Oncol. 115 (2009) 438–442] Gynecologic Oncology. 117: 510 |
Moxley KM, Chengedza S, Benbrook DM. (2009) Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents. Gynecologic Oncology. 115: 438-42 |
Liu T, Masamha CP, Chengedza S, et al. (2009) Development of flexible-heteroarotinoids for kidney cancer. Molecular Cancer Therapeutics. 8: 1227-38 |
Myers T, Chengedza S, Lightfoot S, et al. (2009) Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo. Investigational New Drugs. 27: 304-18 |
Benbrook DM, Lightfoot S, Ranger-Moore J, et al. (2008) Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. Gene Regulation and Systems Biology. 2: 21-42 |